The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Intuitive Surgical, Biogen

Wed, 22nd Jul 2015 13:05

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures fell on Wednesday as corporate earningsdisappointed, especially from Apple, the world's largestcompany. Dow Jones industrial average futures were down0.41 percent at 17,793, S&P 500 futures were down 0.51percent at 2,103.75 and Nasdaq 100 futures were down 1.43percent at 4,599.75.

** APPLE INC, Tuesday close $130.75, -7.18 pctpremarket

The company's fourth-quarter revenue forecast fell short ofestimates and it missed some targets for iPhone sales. Theforecast overshadowed Apple's strong sales in China, which morethan doubled to $13.23 billion from a year earlier.

** INTUITIVE SURGICAL INC, Tuesday close$505.09, +13.14 pct premarket

The Robotic surgical equipment maker reported abetter-than-expected quarterly profit and forecast surgicalprocedures to grow 11 to 13 percent this year, sending itsshares up 13 percent.

** BIOGEN, Tuesday close $409.5, -5.09 pctpremarket

A 6 mg dose of the drugmaker's experimental Alzheimer'sdisease drug significantly reduced beta amyloid plaque in thebrain but failed to significantly slow mental decline,potentially tempering great enthusiasm that greeted data on twoother doses of the treatment earlier this year.

** MICROSOFT CORP, Tuesday close $47.28, -3.34 pctpremarket

The company reported a $3.2 billion quarterly net loss, itsbiggest ever, as the company wrote down its Nokia phone businessand demand fell for its Windows operating system. The companytook a charge of $7.5 billion in the fourth quarter related tothe restructuring of its Nokia handset business, which it boughtlast year.

** YAHOO INC, Tuesday close $39.73, -2.47 pctpremarket

The company forecast lower-than-expected revenue for thecurrent quarter as it struggles to revive its core onlineadvertising business and spends more to attract users to itswebsites.

** CHIPOTLE MEXICAN GRILL INC, Tuesday close$673.07, +2.31 pct premarket

The Burrito chain reported lower-than-expected quarterlyrevenue as the removal of pork products from some of itsrestaurants hurt sales for the second straight quarter. Profitbeat estimates.

** BOEING CO, Tuesday close $145, +2.00 pct premarket

The company reported a 33 percent fall in quarterly profit,hurt by a big charge related to its military tanker program, andcut its 2015 earnings forecast.

** THORATEC CORP, Tuesday close $57.58, +9.38 pctpremarket

** ST JUDE MEDICAL INC, Tuesday close $76.71, -2.24pct premarket

Medical device maker St Jude Medical agreed to buy smallerrival Thoratec Corp for about $3.4 billion to expand itsportfolio of heart failure devices.

** AUTONATION, Tuesday close $64.72, -1.16 pctpremarket

The largest U.S. auto retailer, reported a 15 percent risein quarterly profit as an improving economy and low oil pricesboosted vehicle sales.

** BALLARD POWER SYSTEMS INC, Tuesday close$1.51, +4.64 pct premarket

The Canadian fuel-cell product maker to provide 1 MWClearGen fuel cell distributed generation system for Hydrogenede France. The company said system to be deployed at Akzo NobelNV's AKZO.AS sodium chlorate chemical plant in BordeauxMetropole, France.

** GOPRO INC, Tuesday close $62.04, +2.27 pctpremarket

Action camera maker reported a better-than-expectedquarterly profit and forecast current-quarter revenue abovemarket estimates, helped by strong sales in Asia.

** ASTRAZENECA PLC, Tuesday close $67.64, -0.99 pctpremarket

The company's much anticipated cancer drug pipelinesuffered a modest blow on Wednesday when the experimental drugselumetinib failed to meet its goal in a late-stage trial for arare cancer of the eye.

** BHP BILLITON, Tuesday close $39.68, -3.55 pctpremarket

The company beat its own productionguidance for iron ore in fiscal 2015 and said it was on trackfor additional growth in the current year following majorexpansion work.

** PEABODY ENERGY CORP, Tuesday close $1.2, -1.67pct premarket

Analysts at J.P. Morgan Securities downgraded the coalminer's stock to "neutral" from "overweight", saying stock hascome under "extreme pressure" from short-sellers.

** THERMO FISHER SCIENTIFIC INC, Tuesday close$136.47, +2.66 pct premarket

The world's largest maker of scientific instruments,reported a better-than-expected quarterly profit, helped bylower costs and strength in its life sciences unit.

** INTERPUBLIC GROUP OF COS INC, Tuesday close $19.8

The Advertising company's second-quarter revenue trumpedexpectations for the seventh straight quarter as higheradvertising spending by U.S. businesses made up for the strongdollar's impact on international revenue. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.